Rivermark Medical
Rivermark Medical is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
About Rivermark Medical
Based in the United States, Rivermark Medical is a startup founded in 2020. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Rivermark Medical is a urology-focused medical device company committed to redefining benign prostatic hyperplasia (BPH) treatment through simple, innovative solutions. The company developed the FloStent system, a minimally invasive device designed to treat BPH symptoms by restoring normal urinary flow during routine cystoscopy procedures.
Explore Rivermark Medical's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.